ArticleWorld journal of microbiology & biotechnology2026
rDNA-mediated multicopy integration and gene dosage quantification system for microbial zeaxanthin biosynthesis.
Article in World journal of microbiology & biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Transposon engineering ofEngineering in life sciences · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Zeaxanthin is an oxygenated carotenoid with established physiological functions in ocular health and antioxidant protection. Currently, industrial zeaxanthin production relies primarily on plant extraction and chemical synthesis, which is costly and poses a significant environmental burden. Microbial biosynthesis offers a sustainable and eco-friendly alternative, where the gene dosage of key enzymes critically influences biosynthetic performance. However, optimizing copy number remains challenging for pathways requiring tandem insertion of introduced genes into limited genomic loci. Accordingly, this study developed a genetic system rNTS, which targets the ribosomal non-transcribed spacer region for one-step, high-copy integration of multiple genes and direct assessment of gene dosage effects. Fluorescence Intensity Ratios (FIRs) served as indicators for the direct and quantitative estimation of gene copy number and the selection of optimal dosage. An individual rNTSi (integration) vector integrated up to 40 single-gene copies, while parallel rNTSi vectors enabled multi-gene strains totaling 20 copies with independent visual selection. Following marker removal with rNTSr (removal) vector via the Cre/LoxP system, selection markers were efficiently reused for iterative integrations to achieve 32 copies. Applying rNTS to zeaxanthin biosynthesis rapidly identified the optimal dosage of the rate-limiting enzyme CrtZ, yielding titers of 1.10 g/L under glucose fermentation and 1.19 g/L under methanol-induced fermentation. Owing to its high efficiency, multi-gene copy number readability, and iterative integration capacity, the rNTS strategy offers an additional solution for quantitative gene-dosage assessment and microbial biosynthetic pathway optimization.
Indexed as
Identifiers
42101543What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.